Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride shows promise for female hair loss, but more research needed.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Obesity worsens Polycystic Ovary Syndrome symptoms, and weight loss is a key treatment.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Cholesterol balance is important for hair health, and problems with it can lead to hair loss conditions.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Many young Australian women think they have PCOS, but only a few are diagnosed correctly, causing unnecessary worry.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

No link found between specific genes and female pattern hair loss.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

The document concludes that more research is needed to fully understand the causes of PCOS.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Measuring the distance from the anus to the clitoris may moderately help diagnose polycystic ovary syndrome, especially in certain cases.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.